Lanopepden

DB11912InvestigationalSmall molecule

Lanopepden has been used in trials studying the treatment of Pneumonia, Infections, Bacterial, Skin Diseases, Infectious, and Skin Infections, Bacterial.

Chemical structure of Lanopepden
Formula / weight
C22H34FN7O4 · 479.557 g/mol (avg)
Code names
GSK1322322 · GSK-1322322B

Resolves to

Compound
UNII12M6KFD07ECAS1152107-25-9ChEMBLCHEMBL3301608PubChem52918384
Structure
InChIKeySWHNZGMQMGFQGW-MSOLQXFVSA-NSMILESCC1=NC(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)=C(F)C(=N1)N1CCN2CCOC[C@@H]2C1
Targets
P68826def

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
56Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Lanopepden, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In